C1 Esterase Inhibitor (Human)

CSL Behring

Berinert is a plasma-derived C1 Esterase Inhibitor (Human) indicated for the treatment of acute abdominal, facial, or laryngeal hereditary angioedema (HAE) attacks in adult and pediatric patients (1).

The safety and ef cacy of Berinert for prophylactic therapy have not been established (1).

30 months

Do not store above 25 °C. Do not freeze. Keep the vial in the outer carton in order to protect from light.After reconstitution, the physico-chemical stability has been demonstrated for 48 hours at room temperature (max. 25°C). From a microbiological point of view and as Berinert contains no preservative, the reconstituted product should be used immediately. If it is not administered immediately, storage shall not exceed 8 hours at room temperature. The reconstituted product should only be stored in the vial.